MedTrace Logo

Comparing Pro-Inflammatory Cytokines and Bone Metabolism Mediators Around Laser-Lok and Machined Transmucosal Abutments

NCT03572244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2022-01-03

Study results available
· View outcomes & findings →

Summary

A pilot, prospective, randomized clinical trial is proposed. It is primarily aimed at assessing the expression of pro-inflammatory cytokine and bone metabolism mediators adjacent to Laser-Lok microgrooved (LL) or machined (M) transmucosal healing abutments. The pilot study would seek recruitment of 12 subjects requiring replacement of a single, toothbound molar or premolar in the maxilla or mandible with an implant-supported restoration.

Conditions

  • Dental Implants

Interventions

DEVICE

Laser-Lok

A microgrooved abutment will be placed

DEVICE

Machined

A machined transmucosal healing abutment will be placed

Sponsors & Collaborators

  • BioHorizons, Inc.

    collaborator INDUSTRY

  • Christopher Barwacz

    lead OTHER

Principal Investigators

  • Chris Barwacz, DDS · The University of Iowa College of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-13
Primary Completion
2019-05-24
Completion
2019-05-24
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03572244 on ClinicalTrials.gov